Share on StockTwits

Fibrocell Science (NASDAQ:FCSC) CEO David Pernock purchased 12,500 shares of the stock in a transaction dated Thursday, June 5th. The shares were purchased at an average cost of $2.95 per share, for a total transaction of $36,875.00. Following the completion of the purchase, the chief executive officer now directly owns 22,500 shares in the company, valued at approximately $66,375. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link.

Fibrocell Science (NASDAQ:FCSC) opened at 3.34 on Friday. Fibrocell Science has a 52-week low of $2.70 and a 52-week high of $7.20. The stock has a 50-day moving average of $3.25 and a 200-day moving average of $4.39. The company’s market cap is $136.5 million.

Fibrocell Science (NASDAQ:FCSC) last released its earnings data on Monday, May 19th. The company reported ($0.35) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.15) by $0.20. On average, analysts predict that Fibrocell Science will post $-0.80 earnings per share for the current fiscal year.

Fibrocell Science, Inc is an aesthetic and therapeutic development stage biotechnology company focused on developing novel skin and tissue rejuvenation products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.